Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 96

1.

ERBB4 Expression in Ovarian Serous Carcinoma Resistant to Platinum-Based Therapy.

Saglam O, Xiong Y, Marchion DC, Strosberg C, Wenham RM, Johnson JJ, Saeed-Vafa D, Cubitt C, Hakam A, Magliocco AM.

Cancer Control. 2017 Jan;24(1):89-95.

2.

Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

Morgan RJ Jr, Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Behbakht K, Chen LM, Copeland L, Crispens MA, DeRosa M, Dorigo O, Gershenson DM, Gray HJ, Hakam A, Havrilesky LJ, Johnston C, Lele S, Martin L, Matulonis UA, O'Malley DM, Penson RT, Percac-Lima S, Pineda M, Plaxe SC, Powell MA, Ratner E, Remmenga SW, Rose PG, Sabbatini P, Santoso JT, Werner TL, Burns J, Hughes M.

J Natl Compr Canc Netw. 2016 Sep;14(9):1134-63.

PMID:
27587625
3.

Pelvic squamous cell carcinoma of unknown primary: a case report and review of the literature.

Ahdallah R, Morse B, Hakam A, Shahzad MM.

Eur J Gynaecol Oncol. 2016;37(3):430-3. Review.

PMID:
27352581
4.

Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma.

Matsuo K, Takazawa Y, Ross MS, Elishaev E, Podzielinski I, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Matsuzaki S, Baba T, Satoh S, Shida M, Nishikawa T, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Fujiwara K, Hazama Y, Kadogami D, Moffitt MN, Takeuchi S, Nishimura M, Iwasaki K, Ushioda N, Johnson MS, Yoshida M, Hakam A, Li SW, Richmond AM, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Yamaguchi K, Oishi T, Kajiwara H, Hasegawa K, Yasuda M, Kawana K, Suda K, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Wakatsuki A, Sugiyama T, Pejovic T, Nagano T, Shimoya K, Andoh M, Shiki Y, Enomoto T, Sasaki T, Fujiwara K, Mikami M, Shimada M, Konishi I, Kimura T, Post MD, Shahzad MM, Im DD, Yoshida H, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD.

Ann Oncol. 2016 Jul;27(7):1257-66. doi: 10.1093/annonc/mdw161.

PMID:
27052653
5.

Genetic Investigation of Uterine Carcinosarcoma: Case Report and Cohort Analysis.

Hembree TN, Teer JK, Hakam A, Chiappori AA.

Cancer Control. 2016 Jan;23(1):61-6.

6.

Quantitative DNA methylation analysis of candidate genes in cervical cancer.

Siegel EM, Riggs BM, Delmas AL, Koch A, Hakam A, Brown KD.

PLoS One. 2015 Mar 31;10(3):e0122495. doi: 10.1371/journal.pone.0122495.

7.

BAD-mediated apoptotic pathway is associated with human cancer development.

Stickles XB, Marchion DC, Bicaku E, Al Sawah E, Abbasi F, Xiong Y, Bou Zgheib N, Boac BM, Orr BC, Judson PL, Berry A, Hakam A, Wenham RM, Apte SM, Berglund AE, Lancaster JM.

Int J Mol Med. 2015 Apr;35(4):1081-7. doi: 10.3892/ijmm.2015.2091.

8.

The Chinese herb polyphyllin D sensitizes ovarian cancer cells to cisplatin-induced growth arrest.

Al Sawah E, Marchion DC, Xiong Y, Ramirez IJ, Abbasi F, Boac BM, Bush SH, Bou Zgheib N, McClung EC, Khulpateea BR, Berry A, Hakam A, Wenham RM, Lancaster JM, Judson PL.

J Cancer Res Clin Oncol. 2015 Feb;141(2):237-42. doi: 10.1007/s00432-014-1797-x.

PMID:
25164128
9.

Role of p73 Dinucleotide Polymorphism in Prostate Cancer and p73 Protein Isoform Balance.

Carastro LM, Lin HY, Park HY, Kim D, Radlein S, Hampton KK, Hakam A, Zachariah B, Pow-Sang J, Park JY.

Prostate Cancer. 2014;2014:129582. doi: 10.1155/2014/129582.

10.

Diagnostic digital cytopathology: Are we ready yet?

House JC, Henderson-Jackson EB, Johnson JO, Lloyd MC, Dhillon J, Ahmad N, Hakam A, Khalbuss WE, Leon ME, Chhieng D, Zhang X, Centeno BA, Bui MM.

J Pathol Inform. 2013 Oct 29;4:28. doi: 10.4103/2153-3539.120727.

11.

Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel.

Chen N, Chon HS, Xiong Y, Marchion DC, Judson PL, Hakam A, Gonzalez-Bosquet J, Permuth-Wey J, Wenham RM, Apte SM, Cheng JQ, Sellers TA, Lancaster JM.

Oncol Rep. 2014 Jan;31(1):376-83. doi: 10.3892/or.2013.2847.

12.

Ovarian cancer, version 2.2013.

Morgan RJ Jr, Alvarez RD, Armstrong DK, Burger RA, Chen LM, Copeland L, Crispens MA, Gershenson DM, Gray HJ, Hakam A, Havrilesky LJ, Johnston C, Lele S, Martin L, Matulonis UA, O'Malley DM, Penson RT, Powell MA, Remmenga SW, Sabbatini P, Santoso JT, Schink JC, Teng N, Werner TL, Dwyer MA, Hughes M; National comprehensive cancer networks..

J Natl Compr Canc Netw. 2013 Oct 1;11(10):1199-209.

PMID:
24142821
13.

Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancer.

Marchion DC, Xiong Y, Chon HS, Al Sawah E, Bou Zgheib N, Ramirez IJ, Abbasi F, Stickles XB, Judson PL, Hakam A, Gonzalez-Bosquet J, Wenham RM, Apte SM, Berglund AE, Lancaster JM.

Am J Obstet Gynecol. 2013 Dec;209(6):576.e1-576.e16. doi: 10.1016/j.ajog.2013.08.004.

14.

miR-21, miR-221 and miR-222 expression and prostate cancer recurrence among obese and non-obese cases.

Amankwah EK, Anegbe E, Park H, Pow-Sang J, Hakam A, Park JY.

Asian J Androl. 2013 Mar;15(2):226-30. doi: 10.1038/aja.2012.160.

15.

Primary uterine cervix schwannoma: a case report and review of the literature.

Tahmasbi M, Nguyen J, Ghayouri M, Shan Y, Hakam A.

Case Rep Pathol. 2012;2012:353049. doi: 10.1155/2012/353049.

16.

Ovarian cancer, version 3.2012.

Morgan RJ Jr, Alvarez RD, Armstrong DK, Burger RA, Castells M, Chen LM, Copeland L, Crispens MA, Gershenson D, Gray H, Hakam A, Havrilesky LJ, Johnston C, Lele S, Martin L, Matulonis UA, O'Malley DM, Penson RT, Remmenga SW, Sabbatini P, Santoso JT, Schilder RJ, Schink J, Teng N, Werner TL, Hughes M, Dwyer MA; National Comprehensive Cancer Network..

J Natl Compr Canc Netw. 2012 Nov 1;10(11):1339-49.

PMID:
23138163
17.
18.

Cerebral metastasis of cervical cancer, report of two cases and review of the literature.

Setoodeh R, Hakam A, Shan Y.

Int J Clin Exp Pathol. 2012;5(7):710-4. Review.

19.

Concurrent Paget's disease and basal cell carcinoma of the vulva; a case report.

Abdelbaqi M, Shackelford RE, Quigley BC, Hakam A.

Int J Clin Exp Pathol. 2012;5(6):592-5.

20.

Characterizing the efficacy of fermented wheat germ extract against ovarian cancer and defining the genomic basis of its activity.

Judson PL, Al Sawah E, Marchion DC, Xiong Y, Bicaku E, Bou Zgheib N, Chon HS, Stickles XB, Hakam A, Wenham RM, Apte SM, Gonzalez-Bosquet J, Chen DT, Lancaster JM.

Int J Gynecol Cancer. 2012 Jul;22(6):960-7. doi: 10.1097/IGC.0b013e318258509d.

Supplemental Content

Loading ...
Support Center